AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.672
-0.077 (-10.23%)
Dec 5, 2025, 4:00 PM EST - Market closed
AEON Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 8 | 22 | 268 | 1,395 | 214 | - | |
| Market Cap Growth | -67.75% | -91.93% | -80.82% | 553.24% | - | - | |
| Enterprise Value | 20 | 38 | 252 | 1,642 | 428 | - | |
| Last Close Price | 0.67 | 38.88 | 518.40 | 723.60 | 699.12 | - | |
| PE Ratio | - | 0.51 | - | - | - | - | |
| PB Ratio | - | -0.76 | -1.75 | -10.53 | -2.49 | - | |
| Debt / Equity Ratio | -0.92 | -0.45 | 0.00 | -0.99 | -1.01 | -1.10 | |
| Asset Turnover | - | - | - | - | - | 0.04 | |
| Quick Ratio | 0.72 | 0.00 | 0.40 | 0.12 | 0.25 | 4.81 | |
| Current Ratio | 0.90 | 0.11 | 0.48 | 0.12 | 0.25 | 4.86 | |
| Return on Equity (ROE) | - | - | - | - | - | -968.74% | |
| Return on Assets (ROA) | -165.52% | -348.25% | -374.77% | -351.67% | -166.73% | -15.11% | |
| Return on Capital (ROIC) | - | - | - | -17752.57% | -584.37% | -18.81% | |
| Return on Capital Employed (ROCE) | -3333.40% | 252.80% | 851.60% | 67.50% | 256.70% | -96.30% | |
| Earnings Yield | -0.04% | 194.61% | -143.76% | -3.77% | -26.05% | - | |
| FCF Yield | -166.21% | -94.01% | -17.88% | -2.57% | -13.39% | - | |
| Buyback Yield / Dilution | 91.04% | 99.25% | -3896.62% | -9.98% | -1813.85% | 0.74% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.